Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. May 7, 2006; 12(17): 2793-2797
Published online May 7, 2006. doi: 10.3748/wjg.v12.i17.2793
Published online May 7, 2006. doi: 10.3748/wjg.v12.i17.2793
Figure 1 Clinical course of the patient illustrating the operations (pancreaticoduodenectomy for duodenal GIST and partial resection of recurrence tumor) and IM treatment.
Figure 2 Surgical specimen obtained by pancreaticoduodenectomy of the duodenal GIST.
Figure 3 Immunohistochemical analysis of the duodenal GIST.
A: c-kit; B: CD34; C: S100; D: SMA.
Figure 4 Abdominal MRI showing multiple liver metastases and complete remission in response to imatinib therapy.
Panel A: MRI images of the patient with multiple liver metastases after 3 mo of pancreaticoduodenectomy for malignant duodenal GIST; Panel B: Follow-up MRI images after 1 mo of oral imatinib therapy at 400 mg daily.
Figure 5 PET scan of liver metastases before and after imatinib treatment.
A: pretreatment with imatinib; B: posttreatment with imatinib.
Figure 6 Abdominal CT and MRI showing recurrence of liver metastasis.
A: CT; B: MRI.
Figure 7 Surgical specimen of partial hepatectomy for GIST recurrence.
A: Operative findings; B: Resected specimens.
- Citation: Sakakura C, Hagiwara A, Soga K, Miyagawa K, Nakashima S, Yoshikawa T, Kin S, Nakase Y, Yamaoka N, Sagara Y, Yamagishi H. Long-term survival of a case with multiple liver metastases from duodenal gastrointestinal stromal tumor drastically reduced by the treatment with imatinib and hepatectomy. World J Gastroenterol 2006; 12(17): 2793-2797
- URL: https://www.wjgnet.com/1007-9327/full/v12/i17/2793.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i17.2793